MedPath

Ayurvedic treatment for Grahani Dosha in childre

Phase 2
Conditions
Health Condition 1: K582- Mixed irritable bowel syndrome
Registration Number
CTRI/2024/03/063882
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age: 3-12 years & irrespective of gender

2.Having atleast 3 primary pratyatma lakshnas of Grahani Dosha, i.e. – Atisrushtam or Ativibadhham or Atidravam malapravritti (altered bowel habits)

3.Previously diagnosed case of IBS or fulfilling the standard ROME IV criteria for IBS.

4.Parents / Guardians willing to give informed written consent to participate in the research trial.

Exclusion Criteria

1.Patient suffering from acute infectious disease, metabolic disorder, and any other chronic systemic illness like TB, DM etc.

2.Patient suffering from worm infestations, Amoebic dysentery, acute diarrhoea and Lactose intolerance.

3.Patients suffering from any anorectal disease.

4.Patients who have completed participation in any other clinical trial during the past 6 months.

5.Any condition which the Investigator considers is detrimental to the participant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Regularizing the irregular bowel habits and the consistency of bowel through Bristol Stool Scale in children (3-12 years)Timepoint: Baseline <br/ ><br>After 3 weeks of Intervention <br/ ><br>After 3 weeks of Follow up
Secondary Outcome Measures
NameTimeMethod
1.To evaluate the reduction in other signs & symptoms of Grahani Dosha. <br/ ><br>2.To assess the improvement in the Gastrointestinal Quality of Life Index (GIQLI) Scale. <br/ ><br>3.To assess the improvement in Agni Bala Assessment Scale. <br/ ><br>4.To assess the improvement in Wong-Baker faces pain scale for pediatric age group. <br/ ><br>5.To assess the improvement in IBS Severity Score Scale. <br/ ><br> <br/ ><br>Timepoint: Baseline <br/ ><br>After 3 weeks of Intervention <br/ ><br>After 3 weeks of Follow up
© Copyright 2025. All Rights Reserved by MedPath